SELENBP1 and malignant colon neoplasm: SELENBP1 regulates GPX1 expression in hepatocellular carcinoma (HCC) (Huang et al., 2012), breast cancer (Fang et al., 2010), colon cancer (Fang et al., 2010), and skin cancer (Schott et al., 2018).